Skip to main content English


Peter Ferenci
Prof.Dr.Dr.hc mult Peter Ferenci

Department of Medicine III (Division of Gastroenterology and Hepatology)
Position: Associate Professor

ORCID: 0000-0003-2306-1992
T +43 1 40400 49450


Genetic Diseases, Inborn; Liver Diseases

Research interests

Besides many areas of clinical hepatology I am focussed on the genotype-phenotype association in Wilson disease. Furthermore I am studying possible cofactors for disease expression.

Techniques, methods & infrastructure

Genetic testing

Selected publications

  1. Stättermayer, A.F. et al. (2015) ‘Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations’, Journal of Hepatology, 63(1), pp. 156–163. Available at:
  2. Stättermayer, A.F. et al. (2017) ‘Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome’, Journal of Trace Elements in Medicine and Biology, 39, pp. 100–107. Available at:
  3. Ferenci, P. et al. (2014) ‘ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV’, New England Journal of Medicine, 370(21), pp. 1983–1992. Available at:
  4. Ferenci, P. (2014) ‘Phenotype-genotype correlations in patients with Wilson’s disease’, Annals of the New York Academy of Sciences, 1315(1), pp. 1–5. Available at:
  5. Ferenci P, Członkowska A, Merle U, Szalay F, Gromadzka G, Yurdaydin C, Vogel W, Bruha R, Schmidt HT, Stremmel W. Late onset Wilson disease. Gastroenterology 2007;132:1294-1298